相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas
Dabei Tang et al.
BRAIN TUMOR PATHOLOGY (2021)
PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
Maysaa Abdulla et al.
ACTA ONCOLOGICA (2021)
Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
Hans-Georg Wirsching et al.
CANCERS (2021)
The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling
Melissa Alame et al.
THERANOSTICS (2021)
miR-370 Sensitizes TMZ Response Dependent of MGMT Status in Primary Central Nervous System Lymphoma
Xinwei Li et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma
Yasuo Takashima et al.
PLOS ONE (2020)
PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma
Motomasa Furuse et al.
BMC CANCER (2020)
High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma
Jie Shao et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Immune Checkpoint Molecules in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
Ahmad Monabati et al.
BASIC AND CLINICAL NEUROSCIENCE (2020)
Immune checkpoint inhibitors in malignant lymphoma: Advances and perspectives
Ningjing Lin et al.
CHINESE JOURNAL OF CANCER RESEARCH (2020)
Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma
Tarsheen K. Sethi et al.
LEUKEMIA & LYMPHOMA (2019)
Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL
Yasuo Takashima et al.
SCIENTIFIC REPORTS (2019)
MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma
Yasuo Takashima et al.
PLOS ONE (2019)
The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades
Joe S. Mendez et al.
NEURO-ONCOLOGY (2018)
Primary Central Nervous System Lymphoma
Sarah Loew et al.
SEMINARS IN NEUROLOGY (2018)
The expression of PD-1 ligands and IDO1 by macrophage/microglia in primary central nervous system lymphoma
Yuko Miyasato et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2018)
Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model
Yushi Qiu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma
Simona Ruggieri et al.
ONCOTARGET (2017)
HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?
Marcel Nijland et al.
ONCOIMMUNOLOGY (2017)
Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature
Cristina Izquierdo et al.
NEURO-ONCOLOGY (2016)
Lymphomatous involvement of the central nervous system
G. Bathla et al.
CLINICAL RADIOLOGY (2016)
The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients
Ludovic Nguyen-Them et al.
EUROPEAN JOURNAL OF CANCER (2016)
miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
Pietro Ivo D'Urso et al.
CURRENT GENOMICS (2015)
Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart
Chen Chang et al.
HISTOPATHOLOGY (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Methotrexate re-challenge for recurrent primary central nervous system lymphoma
Elena Pentsova et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
IL-10-1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas
Hema L. Ramkumar et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
RITUXIMAB MONOTHERAPY FOR PATIENTS WITH RECURRENT PRIMARY CNS LYMPHOMA
T. T. Batchelor et al.
NEUROLOGY (2011)
Primary CNS Lymphoma in Immunocompetent Patients
Monica Sierra del Rio et al.
ONCOLOGIST (2009)
Primary lymphoma of the central nervous system: Typical and atypical CT and MR imaging appearances
N Erdag et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2001)
分享论文
